Submitted by Anonymous (not verified) on 24 October 2024 - 14:59
Pharmacovigilance Risk Assessment Committee (PRAC): 28 September - 1 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 28 September 2026 to 1 October 2026
Source: